NEET-PG 2015 - Internal Medicine Practice Questions

Q: In a patient with COPD, what is the best management option?

Quit smoking. ***Quit smoking*** - **Smoking cessation** is the single most effective intervention for slowing the progression of **COPD** and improving lung function [1]. - It reduces exacerbation rates and improves overall mortality, making it the cornerstone of management [1]. *Bronchodilators* - **Bronchodilators** (e.g., beta-agonists, anticholinergics) are crucial for symptomatic relief by opening airways, but they do not alter the disease progression [1]. - While essential for managing symptoms, they are not the "best" in terms of modifying the disease course. *Low flow oxygen* - **Oxygen therapy** is indicated for patients with **severe hypoxemia** (PaO2 < 55 mmHg or SaO2 < 88%) to improve survival and quality of life [2]. - It is a supportive treatment for advanced disease and does not prevent or slow the progression of COPD itself. *Mucolytics* - **Mucolytics** may be used in some patients with COPD and chronic productive cough to reduce sputum viscosity and improve clearance. - Their benefit is primarily symptomatic, and they do not have a significant impact on disease progression or mortality.

Q: What is the most common arrhythmia in ICU patients?

Atrial fibrillation. ***Atrial fibrillation*** - **Atrial fibrillation (AF)** is the most prevalent arrhythmia in the general population [1], and its incidence is significantly higher in critically ill patients due to various stressors. - Factors like **sepsis**, **hypoxemia**, **electrolyte imbalances**, **myocardial ischemia**, and **inflammatory states** common in the ICU are known triggers for new-onset AF. *Atrial flutter* - While atrial flutter is a common arrhythmia, its overall incidence in the ICU setting is **less frequent than atrial fibrillation**. - It often involves a **re-entrant circuit** in the right atrium [2], leading to characteristic "sawtooth" waves on ECG. *Atrial Tachycardia* - Atrial tachycardia is a form of **supraventricular tachycardia (SVT)** that originates in the atria but is **less common** than AF in the ICU [2]. - It often presents as a **regular, narrow-complex tachycardia** with discrete P waves. *Supraventricular Tachycardia* - This is a broad term encompassing arrhythmias that originate **above the ventricles** [3], including AF, atrial flutter, and atrial tachycardia. - While SVT as a category is common, **atrial fibrillation is the single most frequent specific arrhythmia** within this group in the ICU.

Q: Post-tubercular bronchiectasis is most commonly seen with

Tuberculosis. ***Tuberculosis*** - **Tuberculosis (TB)**, particularly childhood TB, is a leading cause of post-infectious bronchiectasis, especially in regions with high TB prevalence [1]. - The inflammatory and destructive processes associated with TB infection in the lungs can lead to irreversible dilation and damage of the bronchi [1]. *Pertussis* - While **pertussis** can cause severe respiratory inflammation and chronic cough, it is a less common cause of widespread, irreversible bronchiectasis compared to tuberculosis [1]. - The damage caused by pertussis is typically more acute and less likely to lead to long-term structural changes like those seen in post-tubercular bronchiectasis. *Cystic fibrosis* - **Cystic fibrosis** is a genetic disorder that causes thick, sticky mucus to build up in the lungs, leading to chronic infections and bronchiectasis [1]. - However, post-tubercular bronchiectasis refers specifically to bronchiectasis developing *after* a tuberculosis infection, not as a primary genetic condition. *Kartagener syndrome* - **Kartagener syndrome** is a genetic disorder characterized by defects in ciliary function, leading to impaired mucociliary clearance and recurrent respiratory infections, which can result in bronchiectasis [1]. - Similar to cystic fibrosis, this is a primary genetic cause of bronchiectasis, distinct from bronchiectasis occurring as a sequela of tuberculosis.

Q: Which of the following is not typically used for secondary prevention of myocardial infarction?

Warfarin. ***Warfarin*** - While Warfarin is an **anticoagulant**, its primary role is in preventing *thromboembolism* in conditions like **atrial fibrillation** [1] or **mechanical heart valves**, not routinely for general **secondary prevention of MI** unless specific indications exist. - Unlike the other options, it doesn't directly address the underlying plaque rupture or reduce the workload of the heart in the typical post-MI patient. *Aspirin* - **Aspirin** is a cornerstone of secondary prevention after MI due to its **antiplatelet** effects, which help prevent future clot formation [2]. - It reduces the risk of recurrent MI, stroke, and cardiovascular death by inhibiting **platelet aggregation** [2]. *Statins* - **Statins** are crucial for secondary prevention as they aggressively lower **LDL cholesterol** levels, stabilizing existing plaques and preventing further plaque progression. - They have pleiotropic effects beyond lipid lowering, including **anti-inflammatory** and **endothelial function improvement**. *Beta blockers* - **Beta blockers** reduce myocardial oxygen demand by decreasing heart rate and contractility, which helps prevent recurrent ischemic events and improves survival post-MI [3]. - They are particularly beneficial in patients with **left ventricular dysfunction** or **hypertension** following an MI [1].

Q: Central bronchiectasis is seen with

Cystic fibrosis. ***Cystic fibrosis*** - **Cystic Fibrosis (CF)** is a genetic disorder commonly associated with **central bronchiectasis**, particularly affecting the upper lobes and central airways. - The abnormal mucus production in CF leads to chronic infection, inflammation, and eventual **dilation of the bronchi**, prominent in the central regions. *Bronchogenic carcinoma* - **Bronchogenic carcinoma** can cause **post-obstructive bronchiectasis** distal to the tumor due to airway obstruction and reduced clearance. - However, the bronchiectasis tends to be **localized** to the segment supplied by the obstructed bronchus, rather than being diffusely central. *Tuberculosis* - **Tuberculosis (TB)** can lead to bronchiectasis, often affecting the **upper lobes** and causing localized airway damage. - While TB can cause changes in the bronchi, it is typically linked with **focal or segmental bronchiectasis** resulting from inflammatory destruction, not diffuse central bronchiectasis like CF. *Cystic Adenomatoid Malformation (CAM)* - **Cystic Adenomatoid Malformation (CAM)** is a **congenital lung lesion** with abnormal airway development, but it does not primarily involve bronchiectasis. - CAM is characterized by **cystic structures** or abnormal lung tissue, not the permanent dilation of the bronchi seen in typical bronchiectasis.

Q: Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?

Atrial fibrillation. ***Atrial fibrillation*** - **Digitalis** (digoxin) is effective in **slowing the ventricular rate** in atrial fibrillation by increasing vagal tone and prolonging the refractory period of the AV node. - In **mitral stenosis**, an uncontrolled rapid ventricular rate due to atrial fibrillation can significantly reduce cardiac output and worsen symptoms. *Right ventricular failure* - While digitalis can improve contractility, its primary role in **RV failure** is not rate control; diuretics and afterload reduction are more commonly used. - A patient with isolated right ventricular failure due to mitral stenosis would not directly benefit from digitalis for rate control. *Acute pulmonary edema* - **Acute pulmonary edema** requires rapid diuresis, oxygen, and vasodilators to reduce preload and afterload. - Digitalis has a slower onset of action and is not the first-line treatment for acute pulmonary edema, especially if the cause is not related to a rapid ventricular rate. *Myocarditis* - **Myocarditis** is an inflammation of the heart muscle, and digitalis is generally avoided due to concerns about potentially worsening arrhythmias and myocardial damage in an inflamed heart. - Treatment for myocarditis focuses on supportive care and addressing the underlying cause, not rate control with digitalis unless specific arrhythmias develop.

Q: Which of the following is seen in sarcoidosis

Increased calcium levels in the blood (Hypercalcemia). ***Increased calcium levels in the blood (Hypercalcemia)*** - In sarcoidosis, activated macrophages in granulomas produce **1-alpha hydroxylase**, which converts **25-hydroxyvitamin D to 1,25-dihydroxyvitamin D (calcitriol)** [1]. - This increased calcitriol leads to enhanced intestinal **calcium absorption** and occasional bone resorption, resulting in **hypercalcemia** [1]. *Decreased calcium levels in the blood (Hypocalcemia)* - **Hypocalcemia** is not characteristic of sarcoidosis; the disease typically involves dysregulated vitamin D metabolism causing elevated, not decreased, calcium [1]. - Conditions like **hypoparathyroidism** or **vitamin D deficiency** (unrelated to the sarcoidosis pathogenesis) would cause hypocalcemia. *Increased phosphate levels in the blood (Hyperphosphatemia)* - **Hyperphosphatemia** is not a feature of sarcoidosis. Calcium and phosphate levels often have an inverse relationship, so with hypercalcemia, phosphate levels tend to be normal or slightly decreased due to suppression of parathyroid hormone. - Hyperphosphatemia is more commonly associated with **renal failure** or certain **endocrine disorders**. *Decreased phosphate levels in the blood (Hypophosphatemia)* - While **hypophosphatemia** can occur in conditions with high vitamin D activity (as increased active vitamin D can promote renal phosphate excretion), it is not the primary or most notable electrolyte disturbance specifically linked to sarcoidosis. - **Hypercalcemia** is the more consistently observed electrolyte abnormality in sarcoidosis related to ectopic vitamin D production [1].

Q: Aspirin sensitive asthma is associated with:

Associated with nasal polyp. **Associated with nasal polyp** - **Aspirin-exacerbated respiratory disease (AERD)**, also known as aspirin-sensitive asthma, is characterized by a triad of **asthma**, **rhinosinusitis with nasal polyposis**, and respiratory reactions to **aspirin** and other NSAIDs [1]. - The presence of **nasal polyps** is a key clinical feature differentiating AERD from other forms of asthma [1]. *Obesity* - While **obesity** can exacerbate asthma severity, it is not specifically associated with the pathogenesis or diagnosis of **aspirin-sensitive asthma**. - It is a general risk factor for various health issues, including more severe asthma, but lacks specificity for AERD. *Extrinsic asthma* - **Extrinsic asthma** (allergic asthma) is typically triggered by environmental allergens and involves an **IgE-mediated response** [2]. - AERD is considered a **non-allergic** or **intrinsic asthma** phenotype, as it is not triggered by traditional allergens but by pharmacologic agents [1]. *Usually associated with urticaria* - **Urticaria** (hives) can be a feature of aspirin and NSAID sensitivity, particularly in some forms of **NSAID-induced urticaria/angioedema**. - However, the classic respiratory reactions of **aspirin-sensitive asthma** (bronchospasm, rhinitis) are distinct from urticarial reactions and typically do not present with primary urticaria.

Q: Which of the following is the common cause of respiratory failure type 2 ?

Chronic bronchitis exacerbation. ***Chronic bronchitis exacerbation*** - **Chronic bronchitis** is a common cause of **Type 2 respiratory failure**, characterized by **hypercapnia** (elevated CO2) due to impaired alveolar ventilation [1]. - An exacerbation worsens **airflow obstruction** and leads to increased work of breathing and CO2 retention [1]. *Acute attack asthma* - While severe asthma can cause respiratory failure, it typically presents initially as **Type 1 (hypoxemic)**, with severe bronchospasm and V/Q mismatch [2]. - **Hypercapnia** in asthma is a sign of **severe, impending respiratory collapse** rather than the primary cause of respiratory failure. *ARDS* - **Acute Respiratory Distress Syndrome (ARDS)** is a classic cause of **Type 1 (hypoxemic) respiratory failure**, characterized by widespread inflammation and fluid accumulation in the lungs [2]. - ARDS primarily involves impaired oxygenation rather than CO2 elimination issues, unless it progresses to severe stages with significant muscle fatigue. *Pneumonia* - **Pneumonia** predominantly causes **Type 1 (hypoxemic) respiratory failure** due to consolidation and V/Q mismatch in affected lung areas, leading to impaired oxygen diffusion [2]. - While severe, widespread pneumonia can eventually lead to ventilatory failure, its initial and primary impact is on oxygenation.

Q: Macular sparing is associated with lesions in:

Lesions in the occipital cortex. ***Lesions in the occipital cortex*** - **Macular sparing** occurs when the central visual field (macula) is preserved despite damage to the occipital cortex, often due to its dual blood supply from the **middle cerebral artery** and the **posterior cerebral artery**. [2] - This phenomenon typically results from a **vascular lesion** in the occipital lobe, leading to a **homonymous hemianopia** with a distinct sparing of the foveal region. [2], [3] *Lesions in the optic nerve* - Lesions in the optic nerve cause **monocular vision loss** or central scotomas, rather than the homonymous visual field defects associated with macular sparing. [2] - Damage here affects the visual pathway **before** the optic chiasm, impacting the entire visual input from one eye. [2] *Lesions in the lateral geniculate body* - Lesions in the **lateral geniculate body (LGB)** produce **contralateral homonymous hemianopia** or quadrantanopia, but typically **do not exhibit macular sparing** as consistently as cortical lesions. - The LGB processes visual information from both eyes before relaying it to the visual cortex. [1] *Lesions in the optic chiasma* - Lesions in the **optic chiasma** classically cause **bitemporal hemianopia**, affecting the temporal visual fields of both eyes. [2] - This type of visual field defect is distinct from the homonymous defects seen with macular sparing, as it results from damage to the **crossing nasal fibers**. [2]

Question 1

In a patient with COPD, what is the best management option?

Accepted Answer

Quit smoking

Answer

Bronchodilators

Answer

Low flow oxygen

Answer

Mucolytics

Question 2

What is the most common arrhythmia in ICU patients?

Accepted Answer

Atrial fibrillation

Answer

Atrial flutter

Answer

Atrial Tachycardia

Answer

Supraventricular Tachycardia

Question 3

Post-tubercular bronchiectasis is most commonly seen with

Accepted Answer

Tuberculosis

Answer

Pertussis

Answer

Cystic fibrosis

Answer

Kartagener syndrome

Question 4

Which of the following is not typically used for secondary prevention of myocardial infarction?

Accepted Answer

Warfarin

Answer

Aspirin

Answer

Statins

Answer

Beta blockers

Question 5

Central bronchiectasis is seen with

Accepted Answer

Cystic fibrosis

Answer

Tuberculosis

Answer

Bronchogenic carcinoma

Answer

Cystic Adenomatoid Malformation (CAM)

Question 6

Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?

Accepted Answer

Atrial fibrillation

Answer

Right ventricular failure

Answer

Acute pulmonary edema

Answer

Myocarditis

Question 7

Which of the following is seen in sarcoidosis

Accepted Answer

Increased calcium levels in the blood (Hypercalcemia)

Answer

Decreased calcium levels in the blood (Hypocalcemia)

Answer

Increased phosphate levels in the blood (Hyperphosphatemia)

Answer

Decreased phosphate levels in the blood (Hypophosphatemia)

Question 8

Aspirin sensitive asthma is associated with:

Accepted Answer

Associated with nasal polyp

Answer

Extrinsic asthma

Answer

Obesity

Answer

Usually associated with urticaria

Question 9

Which of the following is the common cause of respiratory failure type 2 ?

Accepted Answer

Chronic bronchitis exacerbation

Answer

Acute attack asthma

Answer

ARDS

Answer

Pneumonia

Question 10

Macular sparing is associated with lesions in:

Accepted Answer

Lesions in the occipital cortex

Answer

Lesions in the optic nerve

Answer

Lesions in the lateral geniculate body

Answer

Lesions in the optic chiasma

NEET-PG 2015 — Internal Medicine